The 3D genome structure is also disrupted in endocrine-resistant ER+ breast cancer cells6,7, notably through long-range chromatin changes at ER-enhancer binding sites that are DNA hypermethylated in resistant cells7. The gene discussed is ESR1; the disease is breast cancer.